Weight-loss drugs may lower cancer risk, researchers say

Summarised from 2 outlets · Updated 25 Sept, 21:13 · Archive

GLP-1 drugs like Ozempic may lower cancer risk by altering immune response.

Weight-loss drugs such as Ozempic and Wegovy may reduce cancer risk by changing how the body's immune system works, according to researchers. The American Association for Cancer Research's 2026 Cancer Progress Report noted that obesity is a major cancer risk factor. Researchers say further clinical trials are needed to confirm the finding.

How it is being reported

• GLP-1 drugs could play surprising role in cancer risk and outcomesNew York Post · 25 Sept, 19:41
• Popular weight-loss drugs may play surprising role in cancer outcomesFox News · 25 Sept, 12:00

In this story: Ozempic · Wegovy · American Association for Cancer Research

This summary was written by AI from the headlines and standfirsts above, and states as fact only what at least two outlets report. How we use AI · Report a problem